| Literature DB >> 35009011 |
Luis M Hernández Fuentes1, Efigenia Montalvo González2, Maria de Lourdes García Magaña2, Luis M Anaya Esparza2,3, Yolanda Nolasco González1,2, Zuamí Villagrán4, Sughey González Torres4, José Joaquín Velázquez Monreal5, David Antonio Morelos Flores2.
Abstract
The Annonaceae family is one of the oldest angiosperms. The genus Annona is the one with the most species and, together with Asimina, the only ones that contain edible fruits. In the last 10 years, interest in these fruit species has increased, mainly due to their nutritional properties and their application in the treatment of human diseases. Mexico is the center of origin for most of them. However, at present much of the basic agronomic information, postharvest handling of the fruits, and their potential as new crops for areas with poor soils in organic matter or semi-dry climates is unknown. It is considered that these custard apple species may be an option to change towards instead of crops that have lost profitability and sustainability. A review of the current state of knowledge in different areas of the species A. muricata, A. macroprophyllata, A. reticulata, A. squamosa, and A. cherimola was carried out and to focus research efforts on the topics of greatest interest and on those where is required to achieve a sustainable production and use of these resources in Mexico. However, knowledge about the cultivation and potential uses of these species is needed to increase their commercialization; the integration of interdisciplinary and interinstitutional groups is required.Entities:
Keywords: Annona species; Annonaceae; bioactive compounds; biological activity; nutritional quality; perspectives; postharvest technologies
Year: 2021 PMID: 35009011 PMCID: PMC8747276 DOI: 10.3390/plants11010007
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Nutritional composition of edible parts from Annona muricata, A. cherimola, A. squamosa, and A. macroprophyllata fruits.
| Parameter |
|
|
|
|
|---|---|---|---|---|
| Total Energy (kcal) | 55.4–81.73 | 81–102 | 92.9–97.7 | 56.06–89.03 |
| Moisture (%) | 80.48–83.2 | 68.7–70.4 | 65–75 | 71.5–79.61 |
| Protein (%) | 0.69–1.10 | 1.36–1.96 | 0.7–1.89 | 0.44–1.31 |
| Lipids (%) | 0.20–0.97 | 0.10–0.29 | 0.048–0.57 | 0.16–0.31 |
| Soluble carbohydrates (%) | 12.50–18.23 | 13.0–29.0 | 20.41–25.19 | 13.55–20.25 |
| Dietary fiber (%) | 4.83–5.76 | 2.09–5.32 | 0.62–1.41 | 0.97–1.30 |
| Minerals (mg/100 g) | ||||
| Calcium | 9.0–10.3 | 9.0–27.14 | 17.0–44.7 | 0.86–31.60 |
| Phosphorous | 27.7–29.0 | 24.0–35.20 | 54.0 | 51.7 |
| Iron | 0.64–0.82 | 0.25–0.60 | 0.3–1.34 | ND |
| Magnesium | 22.0 | 17 | 21.0–22.0 | 8.0–14.01 |
| Copper | ND | ND | 0.086 | ND |
| Manganese | ND | ND | 0.10 | ND |
| Zinc | ND | 0.16 | 0.1 | 0.10–0.13 |
| Potassium | 320 | 288 | 142 | 335.95–347.40 |
| Vitamins (mg/100 g) | ||||
| Vitamin C | 22.59–40.56 | 12–6–25.43 | 25.6–58.75 | 1.51–13.6 |
| Vitamin E | 29 | 0.27 | ND | ND |
| Thiamin | 0.11–2.10 | 0.09–0–0.11 | 0.10 | 0.24 |
| Riboflavin | 0.05–0.2 | 0.11–0.13 | 0.06 | 0.30 |
| Niacin | 0.21–1.52 | 0.65–1.0 | 0.89 | 2.18 |
| Cobalamin | ND | 0.12 | ND | ND |
|
| [ | [ | [ | [ |
ND = No determined.
Bioactive compounds: phenolic compounds and fatty acids from different plant components of some Annona species.
| Plant Part | Bioactive Compounds | Content | References | |
|---|---|---|---|---|
|
| ||||
|
| Pulp | Chlorogenic acid | 12.80 | [ |
| Cinnamic acid | 42.04 | |||
| Coumaric acid | 0.07 | |||
| Gallic acid | 15.86 | |||
| 4-Hydroxybenzoic acid | 131.63 | |||
| Neochlorogenic acid | 72.32 | |||
| Dicaffeoylquinic acid, caffeoylquinic acid, fisetin, dihydrokaempferol-hexoside, morin, kaempferol 3- | NR | [ | ||
| Leaf | Caffeoylquinic acid, chlorogenic acid, dicaffeoylquinic acid, feruloylquinic acid, cinnamic acid, isoferulic acid, caffeic acid, gallic acid, apigenin-6-C-glucoside, argentinine, catechin, coumaric acid, daidzein, epicatechin, gallocatechin, genistein, glycitein, homoorientin, kaempferol, kaempferol 3- | NR | [ | |
| Peel | Gallic acid | 14.50 | [ | |
| Coumaric acid | 1.37 | |||
| Cinnamic acid | 45.51 | |||
| Caffeic acid | 43.68 | |||
| Chlorogenic acid | 32.67 | |||
| Protocatechuic acid | 150.46 | |||
| 4-Hydroxybenzoic acid | 145.98 | |||
| Syringic acid | 883.71 | |||
| Neochlorogenic acid | 78.86 | |||
| Seed | Gallic acid | 0.36 | [ | |
| Coumaric acid | 0.07 | |||
| Cinnamic acid | 40.48 | |||
| Caffeic acid | 32.62 | |||
| Chlorogenic acid | 12.33 | |||
| Protocatechuic acid | 133.47 | |||
| Syringic acid | 780.77 | |||
| Neochlorogenic acid | 69.70 | |||
|
| Pulp | Catechin, procyanidin (B-type) dimer isomer, (epi)catechin-(epi)gallocatechin, epicatechin, derivates of procyanidin trimer | NR | [ |
| Leaf (mg/100 g dw) | Catequin | 12.42–24.5 | [ | |
| Quercetin 3- | 1.06–16.16 | |||
| Epicatechin | 6.33–26.31 | |||
| Quercetin 3- | 32.25–75.29 | |||
| Quercetin 3- | 719.53–2593.92 | |||
| Kaempferol-3-Galactoside-7-Rhamnoside | 55.74–620.98 | |||
| Kaempferol-3- | 22.44–337.09 | |||
| Luteolin-3-Galactoside-7-Rhamnoside | 47.49–120.58 | |||
|
| Leaf | Quercetin, quercetin 3- | NR | [ |
| Seed | Gallic acid, ρ-hydroxybenzoic acid, syringic acid, ferulic acid, ellagic acid, benzoic acid, o-coumaric acid, and salicylic acid | NR | [ | |
|
| Peel (mg/100 g) | Chlorogenic acid | 84 | [ |
| Ferulic acid | 34.9 | |||
| p-hydroxybenzoic | 20.90 | |||
| Caffeic acid | 6.6 | |||
| Gallic acid | 4.9 | |||
| Epicatechin | 102 | |||
| Seed (%) | Oleic acid | 70.42 | [ | |
| Palmitic acid | ||||
|
| Seed (%) | Linoleic acid | 25.5 | [ |
| Stearic acid | 1.5 | |||
| Stearic acid | 6.0 | |||
| Oleic acid | 39.5 | |||
| Linoleic acid | 27.0 | |||
|
| Seed (%) | Myristic acid | 0.05 | [ |
| Palmitic acid | 14.91 | |||
| Heptadecanoic acid | 0.21 | |||
| Stearic acid | 7.60 | |||
| Palmitoleic acid | 0.32 | |||
| Oleic acid | 35.20–43.72 | |||
| Linoleic | 32.48–44.93 | |||
|
| Seed (%) | Oleic acid | 41.9 | [ |
| Palmitic acid | 14.7 | |||
| Linoleic acid | 26.6 | |||
| Stearic acid | 11.3 | |||
| Hexadenoic acid | 10–14 | |||
| Hepatadecene-(8)-carbonic acid (1) | 29.68 | |||
| Cis-vaccenic acid | 10.39 | |||
| Heneicosanoic acid | 3.20 | |||
| 9-octadecenoic acid (Z)-,2,3-dihydroxy propyl ester | 13.33 |
NR = Not reported.
Bioactive compounds: cyclopeptides, alkaloids, and acetogenins from different plant components of some Annona species.
| Plant Part | Bioactive Compound | References | |
|---|---|---|---|
|
| |||
|
| Seed | Annomuricatin A-C | [ |
|
| Seed | Cherimolacyclopeptide E, herimolacyclopeptide F | [ |
|
| Seed | Cyclosquamosins A–G, | [ |
| cyclosquamosin, met-cherimolacyclopeptide B | |||
| Peel | Fanlizhicyclopeptide A-B | [ | |
|
| |||
|
| Root, bark | Anomurine, anomuricine, atherosperminine, coreximine, coclaurine | [ |
| Stem | Atherospermine, casuarine, 2,5-dihydroxymethyl-3,4,dihydroxypyrrolidine, deoxymannojirimycin, deoxynojirmycin | [ | |
| Leaf | Stepharine, coclaurine, coreximine, annonaine, asimilobine, 2,5-dihydroxymethyl-3,4,dihydroxypyrrolidine, deoxymannojirimycin, deoxynojirmycin, swainsonine, (R)-O,O-dimethylcoclaurine, annonamine, R)-4′O-methylcocaurine, S)-narcorydine, xylopine, N-methylcoclaurine, remerine, isoboldine, isolaureline, liriodenine, reticuline, N-methylcoculaurine | [ | |
| Fruit | Nornuciferine, annonaine, asimilobine | [ | |
| Peel | Nornuciferin, assimilobin, anonaine, isolaureline | [ | |
|
| Leaf | Liriodenine, anonaine, nornuciferine, 1,2- dimethoxy-5,6,6a,7-tetrahydro-4 h, dibenzoquinoline-3,8,9,10-tetraol, asimilobine, pronuciferine | [ |
| Root | Corytenchine, isocoreximine | [ | |
|
| Leaf | Reticuline, o-methylarmepavine, annonaine, oxophoebine, lysicamine, n-methylcoclaurine, liriodenine, corydine, lanuginosine, roemerine, corypalmine, sanjoinine, norlaureline, norcodeine, oxalanobie, aporphine | [ |
| Seed | Annonaine, asimilobine, liriodenine, corypalmine, reticuline, nornuciferine | [ | |
| Stem bark | Roemerolidine, | [ | |
|
| Seed | Rolliniastatin-2, laherradurin, cherimolin-2 and liriodenine | [ |
| Root, Stem bark, leaf | Liriodenine, atherospermidine, lysicamine | [ | |
|
| |||
|
| Pulp | Montecristin, epomuricenins A-B, epoxymurin, epomurinins A-B, epomusenins A-B, annonacin, corossolone, muricatin C, muricin, montanacin | [ |
| Leaf | Annocatalin, annohexocin, annomuricin A-E, annomutacin, annonacin, annopentocin A-C, corossolone, gigantetronenin, goniothalamicina, montanacin, muricapentocin, muricatalicin, muricin, muricatalin, muricatocin A-C, murihexocin, muricoreacin, solamin | [ | |
| Seed | Ronbusticin, annomuricatin A, cohibin A-D, donhexocin, muricatenol, murihexol, epomuricenins A-B, corepoxylone, Epoxyrollin B, annoglaxin, annomontacin, annonacin, annoreticuin-9-one, arianacin, corossolina, corossolona, gigantetrocin A-B, goniothalamicina, muricatetrocin A-B, Muricatin A-D, muricin A-I, murisolina, solamin, bullatacilin, bullatacin, gigantecin, annocatacin | [ | |
| Root | Cohibin A-B, montecristin, epomuricenins A-B, sabadelin, annonacin | [ | |
| Stem bark | Muricatin C | [ | |
|
| Pulp | Bullatacin, annonacin | [ |
| Leaf | Molvizarin, cherimolin-1, motrilin, annonacin, annonisin | [ | |
| Seed | Cherimolin, dihydrocherimolin, molvizarin, motrilin, itrabin, jetein, cherimolin-2, almunequin, annomolin, annocherimolin | [ | |
| Stem bark | Aromin-A, squamocin | [ | |
| Leaf | Murihexocin C | [ | |
|
| Seed | Annotemoyin, squamocin, annoglaxin, epoxyrolin, murisolin, neo- desacetyluvaricin, squamostatin, annosquamins, bullatacin, annosquacin, annosquatin, annonareticin, motrilin, solamin, squadiolin, squamoxinone, squamostanin, uvarigrandin, squamostolide, tripoxyrollin, uvariamicin | [ |
| Stem bark | 4-deoxyannoreticuin, | [ | |
|
| Seed | Laherradurin, rolliniastin-2, and cherimolin-2 | [ |
Cytotoxicity, anti-hyperglycemic, and anti-inflammatory activities of different crude extracts or isolated compounds from different plant parts of some Annona species using different model assays.
| Activity/ | Plant Part | Bioactive | Dose/Concentration | Model Assay | Effect | References |
|---|---|---|---|---|---|---|
|
| ||||||
|
| Leaf | Annonacin | 85 nM | Mice induced a skin tumorogenesis | To reduce the tumor incidence, tumor burden, and tumor volume | [ |
| Acetogenin-rich fraction | 100 and 200 mg/kg for 7 days | Rats induced benign prostatic hyperplasia (PSA) | The fractions (200 mg/kg) significantly reduced the PSA level | [ | ||
| Root-bark, fruit, leaf | Ethyl acetate extract | 50 µg/mL | MCF-10A cell line (breast) | The fractions had the highest anticancer abilities | [ | |
| Stem bark | Annonacin and ethyl acetate extract | IC50 0.1 μM and 55.501 μg/mL | DU-145 prostate carcinoma cells | Annonacin and extract displayed selective and potent cytotoxicity | [ | |
|
| Seed | Annomolin, annocherimolin | A-549 (lung), MCF-7 (breast), HT-29 (colon), A-498 (kidney), PC-3 (prostate) and MIA PaCa-2 (pancreas) cell lines | Potent cytotoxicity against all cell lines | [ | |
| Ethanolic extract | IC50 23.20 μg/mL | Colorectal cancer cell lines: T84, HCT-15, SW480 and HT-29, cancer stem cells | Potential cytotoxic activity on T-81 and HCT-15 resistant cell lines | [ | ||
| Leaf | Ethanolic extract | IC50 390.20 μg/mL | Breast cancer cell lines: MDA-MB-231 and MCF-7 | Selective antiproliferative and pro-apoptotic activities | [ | |
|
| Stem bark | Bullatacin | IC50 of 2.47 × 10−7 µg/mL | A-549, HT-29, MCF-7, A-498, PC3 and PACA-2 cell lines | Selective cytotoxic activity against MCF-7 cells | [ |
| Seed | Acetogenins | IC50 ranged from 2.2 × 10−1 to 8.3 × 10−3 µg/mL | HeLa, MCF-7, A-549, Hep-G2, SMMC-7721 and MKN-45 cell lines | Selective cytotoxic activity against MCF-7 and A-549 cells | [ | |
| Leaf | Methanolic extract | IC50 ranged from 1.1 to 2.1 µg/mL | Human immortalized line of T lymphocyte (Jurkat), MCF-7, HL60, and HCT-116 | Leaf extract was more active against MCF-7 cells, likewise for seed extract against Jurkat and HL60 cells | [ | |
| Seed, peel, pulp | Aqueous extract | IC50 7.31 ± 0.03 and 15.99 ± 1.25 µg/mL | Cancer cell lines colon (Caco-2), prostate (PC3), liver (HepG-2), and breast (MCF-7) | Seed extracts had the lowest IC50 values for PC-3 and MCF-7 cancer cell lines | [ | |
|
| Seed | Cherimolin-2 | IC50 of 0.5 µg/mL for SW-480 and for HeLa 0.05 µg/mL. In vivo doses 500 mg/kg body weight, 20 days | HeLa and SW-480 cell line and rats injected with HeLa (1 × 106) or SW-480 (5 × 106) cells | Size reduction of HeLa tumor (43%), and 16% of SW-480 tumor | [ |
| Laherradurin | IC50 of 0.15 µg/mL for HeLa and SW-480. In vivo doses 500 mg/kg body weight 20 days | HeLa and SW-480 cell line and rats injected with HeLa (1 × 106) or SW-480 (5 × 106) cells | Size reduction of HeLa tumor (64%) and SW-480 tumor (60%) | [ | ||
|
| ||||||
| Leaf | Aqueous extract | 100 mg/kg for 2 weeks | Streptozotocin-induced diabetic rats, | Significant reduction of blood glucose levels and protective action on pancreatic β-cells | [ | |
|
| Dry extract | 100 mg/kg/day for 4 weeks | Streptozotocin-induced diabetic rats. | The dry extract improves behavioral alterations and protects testis in diabetic animals | [ | |
| Steam bark | Ethanolic extract | 150 and 300 mg/kg for 2 weeks | Alloxan-induced diabetic male albino rats | [ | ||
|
| Leaf | Ethanolic extract | 300 mg/kg, one week | Alloxan-induced type 2 diabetic (AITD) | Attenuated postprandial hyperglycemia | [ |
| Aqueous extract (infusion) (1.5 g/mL) | 300 mg/kg | Streptozocin-induced diabetic mice | Reduction of the blood glucose level, glycated hemoglobin, cholesterol, and triacylglycerols | [ | ||
|
| Leaf | Aqueous extract | 300 mg/kg body weight | Streptozotocin-induced Wistar rats | Decreased glucose and increased insulin sensitivity | [ |
| Ethanolic extract | 100 mg/kg body weight | Streptozotocin-induced rats | Glycemia decreased as well as glycated hemoglobin, creatinine, and urea | [ | ||
| Root | Aqueous extract | 500 mg/kg body weight | Streptozotocin-induced hyperglycemic rats | A significant reduction of glycemia, 6 h after oral administration | [ | |
| Leaf and peel | Aqueous extract | 250 mg/kg body weight | Streptozotocin-induced diabetic rats | Improvement of the glycemia and lipid profile | [ | |
|
| Leaf | Ethanolic extract | 200 mg/kg body weight | Alloxan-induced diabetic Balb-c mice | A significant decrease in postprandial hyperglycemia | [ |
| Aqueous extract | 300 mg/kg body weight | Healthy rats | Reduction of glycemia at a dose-dependent manner | [ | ||
|
| ||||||
|
| Fruit | Aqueous extract | 50, 100 and 200 mg/kg | Carrageenan-induced paw edema rats and xylene-induced-ear edema rats | Significant anti-inflammatory activity on paw edema and ear edema | [ |
| Leaf | Aqueous extract | 100 mg/kg body weight | Female Balb/c albino mice injected with | The extract minimized the inflammation by decreasing the expression levels of IL-1β and TNF-α | [ | |
| Ethanolic extract | 100, 200, and 400 mg/kg orally for 7 days | Rectoanal tissue from Swiss mice | All three doses show significant anti-inflammatory effects on hemorrhoidal tissue | [ | ||
|
| Leaf | Ethanolic extracts | 100 mg/kg | Rats (Leukocyte migration to the peritoneal cavity and Subcutaneous air pouch test) | The inhibitory effect of the ethanolic extract on leukocytes migration was 63.8 and 73.16% | [ |
|
| Root | Ethanolic extract | 400 mg/kg body weight | Carrageenan-induced paw edema rats | Inhibition (54%) of edema inflammation at 400 mg/kg | [ |
| Stem bark | Caryophyllene oxide | 25 mg/kg body weight | Acetic acid-induced Swiss albino rats | Inhibition of inflammation (75% ) at 25 mg/kg | [ | |
| 18-acetoxyent-kaur-16-ene | 25 mg/kg body weight | Acetic acid-induced rats | Inhibition of inflammation 62%) at 25 mg/kg | [ | ||
Postharvest technologies or treatments to extend the shelf life of fruit of the genus Annona.
| Technology/Treatment | Genus | Effect | References |
|---|---|---|---|
| Aqueous extract of coconut mesocarp + commercial chitosan | Control of | [ | |
| Electrolyzed solution with neutral pH | Sporicidal activity | [ | |
| Hydrothermal, fungicidal, and wax treatment | Browning control | [ | |
| Edible mucilage coating | Preservation of the physicochemical characteristics and extending the shelf life (2 extra days) | [ | |
| 1-Methylcyclopropene | Preservation of physicochemical characteristics | [ | |
| Chitosan coating | Anthracnose control | [ | |
| Chitosan coating | Control of physicochemical, microbiological, and sensory characteristics | [ | |
| Cold storage | Increase the days of shelf life of the fruit (2 extra days) | [ | |
| Biocontrol of postharvest anthracnose | [ |